文献速递颈动脉与弓上血管

大型单中心经验中经颈动脉血运重建与颈动脉内膜剥脱术的临床结局比较

Clinical outcomes of transcarotid artery revascularization vs carotid endarterectomy from a large single-center experience.
PubMed 文献 · J Vasc Surg · 2024-02-05

本单中心回顾性研究纳入646例手术(404例颈动脉内膜剥脱术CEA、242例经颈动脉血运重建TCAR),比较围手术期及晚期结局。倾向性匹配后,两者围手术期临床结局相似;但CEA在晚期卒中/死亡率和≥80%再狭窄率上似乎优于TCAR,其中晚期卒中/死亡差异有统计学意义,而再狭窄差异未达统计学显著。

要点

  • 倾向性匹配后,CEA与TCAR围手术期卒中、卒中/死亡、颅神经损伤发生率无显著差异。
  • 匹配后晚期随访中,CEA的卒中/死亡率8% vs TCAR 15%(P=0.0345),差异有统计学意义。
  • 匹配后CEA的≥80%再狭窄率0.9% vs TCAR 3%,但差异未达统计学显著(P=0.099)。

核心结论

  • 在倾向性匹配分析中,CEA与TCAR的围手术期临床结局相似;但CEA在晚期卒中/死亡率上优于TCAR,且2年时≥80%再狭窄率略低,但该差异未达统计学显著。

研究设计与样本

  • 本研究为单中心回顾性分析,纳入本机构TCAR监测项目患者,并与同一时期同一批术者完成的CEA患者进行比较。
  • 共分析646例手术(637例患者),其中CEA 404例、TCAR 242例;采用倾向性匹配分析结局,匹配242例CEA与242例TCAR。
  • 主要结局为围手术期卒中/死亡与晚期卒中/死亡的复合结局;次要结局包括卒中、死亡和心肌梗死的复合结局、颅神经损伤(CNI)及出血。
  • 采用Kaplan-Meier分析估计免于卒中、卒中/死亡以及≥50%和≥80%再狭窄的率。

主要发现

  • TCAR患者具有更多高危标准,包括高血压、冠状动脉疾病、充血性心力衰竭和肾功能衰竭;两组颈动脉干预指征无显著差异。
  • 未匹配队列中,CEA vs TCAR的30天围手术期卒中为1% vs 2%,卒中/死亡率为1% vs 3%(P=0.0849),大血肿为2% vs 2%;CNI为5% vs 1%(P=0.0138)。
  • 未匹配队列晚期随访(2年)中,CEA vs TCAR的卒中率为1% vs 4%(P=0.0273),卒中/死亡为8% vs 15%(P=0.008),≥80%再狭窄为0.5% vs 3%(P=0.0139)。
  • 匹配后,CEA vs TCAR的围手术期卒中为1% vs 2%(P=0.5037),卒中/死亡为2% vs 3%(P=0.2423),CNI为3% vs 1%(P=0.127)。
  • 匹配后晚期随访中,CEA vs TCAR的卒中率为1% vs 4%(P=0.0615),卒中/死亡为8% vs 15%(P=0.0345),≥80%再狭窄为0.9% vs 3%(P=0.099)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcarotid artery revascularization (TCAR) has been practiced as an alternative for both carotid endarterectomy (CEA) and transfemoral carotid artery stenting, specifically in high-risk patients. More recently, the Centers for Medicare and Medicaid Services expanded coverage for TCAR in standard surgical risk patients if done within the Society for Vascular Surgery Vascular Quality Initiative TCAR surveillance project. A few registry studies (primarily from the Society for Vascular Surgery Vascular Quality Initiative) compared the early and up to 1-year outcomes of TCAR vs CEA or transfemoral carotid artery stenting. There is no large single-center study that reported late clinical outcomes. The present study compares intermediate clinical outcomes of TCAR vs CEA. METHODS: This study retrospectively analyzed collected data from TCAR surveillance project patients enrolled in our institution and compare it with CEA patients done by the same providers at the same time period. The primary outcome was combined perioperative stroke/death and late stroke/death. Secondary outcomes included combined stroke, death, and myocardial infarction, cranial nerve injury (CNI), and bleeding. Propensity matching was done to analyze outcome. Kaplan-Meier analysis was used to estimate freedom from stroke, stroke/death, and ≥50% and ≥80% restenosis. RESULTS: We analyzed 646 procedures (637 patients) (404 CEA, 242 TCAR). There was no significant difference in the indications for carotid intervention. However, TCAR patients had more high-risk criteria, including hypertension, coronary artery disease, congestive heart failure, and renal failure. There was no significant differences between CEA vs TCAR in 30-day perioperative stroke (1% vs 2%), stroke/death rate (1% vs 3%; P = .0849), or major hematomas (2% vs 2%). The rate of CNI was significantly different (5% for CEA vs 1% for TCAR; P = .0138). At late follow-up (2 years), the rate of stroke was 1% vs 4% (P = .0273), stroke/death 8% vs 15% (P = .008), ≥80 % restenosis 0.5% vs 3% (P = .0139) for CEA patients vs TCAR patients, respectively. After matching 242 CEAs and 242 TCARs, the perioperative stroke rate was 1% for CEA vs 2% for TCAR (P = .5037), the stroke/death rate was 2% vs 3% (P = .2423), and the CNI rate was 3% vs 1% (P = .127). At late follow-up, rates of stroke were 1% for CEA vs 4% for TCAR (P = .0615) and stroke/death were 8% vs 15% (P = .0345). The rate of ≥80% restenosis was 0.9% for CEA vs 3% for TCAR (P = .099). The rates of freedom from stroke at 6, 12, 18, and 24 months for CEA vs TCAR were 99%, 99%, 99%, and 99% vs 97%, 95%, 93% and 93%, respectively (P = .0806); stroke/death were 94%, 90%, 87%, and 86% vs 93%, 87%, 76%, and 75%, respectively (P = .0529); and ≥80% restenosis were 100%, 99%, 98%, and 98% vs 97%, 95%, 93%, and 93%, respectively (P = .1132). CONCLUSIONS: In a propensity-matched analysis, both CEA and TCAR have similar perioperative clinical outcomes. However, CEA was superior to TCAR for the rates of late stroke/death and had a somewhat lower rate of ≥80% restenosis at 2 years, but this difference was not statistically significant.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. AbuRahma AF, Santini A, AbuRahma ZT, et al. Clinical outcomes of transcarotid artery revascularization vs carotid endarterectomy from a large single-center experience. J Vasc Surg. 2024. PMID: 38320692. doi:10.1016/j.jvs.2024.01.213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。